Evidence map›Paper›PMID 39308660›Full record

ArticleClinical case reports2024

The significance of therapeutic drug monitoring in detecting low medication adherence in patients with cancer: A case study of cabozantinib.

Shinichi Maruyama, Kenji Momo, Tadatsugu Anno, Masaru Ishida, Hiroshi Kanno, Masaru Kato

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shinichi MaruyamaDepartment of Bioanalytical Chemistry Showa University Graduate School of Pharmacy Shinagawa-ku Japan.ORCID https://orcid.org/0009-0008-1386-8112
Kenji MomoDepartment of Hospital Pharmaceutics, School of Pharmacy Showa University Shinagawa-ku Japan.ORCID https://orcid.org/0000-0001-9856-0097
Tadatsugu AnnoDepartment of Urology Saiseikai Yokohamashi Tobu Hospital Yokohama city Japan.
Masaru IshidaDepartment of Urology Saiseikai Yokohamashi Tobu Hospital Yokohama city Japan.
Hiroshi KannoDepartment of Pharmacy Saiseikai Yokohamashi Tobu Hospital Yokohama city Japan.
Masaru KatoDepartment of Bioanalytical Chemistry Showa University Graduate School of Pharmacy Shinagawa-ku Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maintaining good medication adherence is important for providing desirable outcomes from medication therapy. We showed that therapeutic drug monitoring (TDM) contributed to the identification of low medication adherence to cabozantinib in a patient with cancer. We present an educational case to assist with understanding TDM in a patient with cancer.

Indexed as

cabozantinibhigh performance liquid chromatographykidney cancermedication compliancetherapeutic drug monitoringtyrosine kinase inhibitor

Identifiers

PMID39308660
PMCPMC11413627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.